Rodríguez LLA, Quenta TRR, Rodríguez ME

Language: Spanish
References: 17
Page: 463-467
PDF size: 753.27 Kb.

ABSTRACT

Dengue's cardiological manifestations are diverse; the virus is able to enter the myocardium and cause acute myocarditis that sometimes may go unnoticed and be asymptomatic, with benign outcomes; while in others, it may produce electrocardiographic rhythm and conduction disturbances or signs of ventricular dysfunction that could lead to severe heart failure. We present the case of a 21-year-old man, a student, previously healthy, who was admitted to the Department of Cardiology with a diagnosis of dengue confirmed by serology and complicated with conduction disorders (2:1 advanced atrioventricular block) related to acute myocarditis due to dengue. This problem can be seen in areas where dengue is an emerging problem. Therefore it is critical to be aware of it in order to design strategies for prevention and treatment of complications.

REFERENCES

1. WHO Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization [Internet]; 2009 [citado 30/11/2020]. Disponible en: http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf

2. Gómez-Ochoa SA. Viremia en plasma como factor asociado a gravedad en la infección por el virus del dengue: revisión sistemática de la literatura. Rev Chilena Infectol. 2018;35(2):176-83.

3. Ministerio de Salud (Argentina). Guía para el Equipo de Salud Nro. 2 (4ta. edición). Enfermedades infecciosas: Dengue. Buenos Aires: Dirección de Epidemiología - Ministerio de Salud de la Nación [Internet]; 2015 [citado 30/11/2020]. Disponible en: https://www.sadi.org.ar/rss/item/713-guia-para-el-equipo-de-salud-sobre-dengue

4. Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis - Diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015;12(11):670-80.

5. Guzman MG, Harris E. Dengue. Lancet. 2015;385(9966):453-65.

6. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg. 1993;48(3):324-31.

7. Tamayo Escobar OE, García Olivera TM, Escobar Yéndez NV, González Rubio D, Castro Peraza O. La reemergencia del dengue: un gran desafío para el sistema sanitario latinoamericano y caribeño en pleno siglo XXI. MEDISAN [Internet]. 2019 [citado 30/11/2019];23(2):308-24. Disponible en: http://scielo.sld.cu/pdf/san/v23n2/1029-3019-san-23-02-308.pdf

8. Guadalajara-Boo JF, Ruiz-Esparza ME, Aranda Frausto A, Soto Abraham MV, Gaspar-Hernández J. Imagen histológica y angiocardiográfica de miocarditis aguda por dengue. Rev Esp Cardiol. 2014;67(3):226-7.

9. Póvoa TF, Alves AM, Oliveira CA, Nuovo GJ, Chagas VL, Paes MV. The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One [Internet]. 2014 [citado 5/12/2019];9(4):e83386. Disponible en: https://doi.org/10.1371/journal.pone.0083386

10. Doyen D, Moceri P, Ducreux D, Dellamonica J. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet. 2020;395(10235):1516.

11. Irabien-Ortiz Á, Carreras-Mora J, Sionis A, Pàmies J, Montiel J, Tauron M. Miocarditis fulminante por COVID-19. Rev Esp Cardiol. 2020;73(6):503-4.

12. Aslam M, Aleem NA, Zahid MF, Rahman AJ. Unusual presentation of Dengue Fever: A child with acute myocarditis. Sultan Qaboos Univ Med J. 2016;16(1):e101-4.

13. de Mel S, Mowjood R, Kapuruge L, de Mel C, Path D. Mobitz type I atrio-ventricular block in dengue myocarditis, requiring temporary pacing. IDCases. 2015;2(4):99-101.

14. Lee IK, Lee WH, Liu JW, Yang KD. Acute myocarditis in dengue hemorrhagic fever: a case report and review of cardiac complications in dengue-affected patients. Int J Infect Dis. 2010;14(10):e919-22.

15. La-Orkhun V, Supachokchaiwattana P, Lertsapcharoen P, Khongphatthanayothin A. Spectrum of cardiac rhythm abnormalities and heart rate variability during the convalescent stage of dengue virus infection: a Holter study. Ann Trop Paediatr. 2011;31(2):123-8.

16. Pothapregada S, Kamalakannan B, Thulasingam M. Clinical profile of atypical manifestations of Dengue Fever. Indian J Pediatr. 2016;83(6):493-9.

17. Bertomeu-González V, Pombo M, Chimeno J, Lillo IM, Cano O. Estimulación cardiaca tras pandemia de la COVID-19. Propuesta de desescalada de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología. REC CardioClinics. 2020;55(3):170-6.